Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US-12006555-B2 · Jun 11, 2024 · US
Johnson Bruce E is listed as an inventor on 17 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Johnson Bruce E |
| Total patents | 17 |
| First publication | Mar 31, 2015 |
| Latest publication | Jun 11, 2024 |
Publications ranked by popularity score, then publication date.
US-12006555-B2 · Jun 11, 2024 · US
US-11009508-B2 · May 18, 2021 · US
US-2021017604-A1 · Jan 21, 2021 · US
US-10841241-B2 · Nov 17, 2020 · US
US-10669589-B2 · Jun 2, 2020 · US
US-2019207869-A1 · Jul 4, 2019 · US
US-2019145977-A1 · May 16, 2019 · US
US-10243879-B2 · Mar 26, 2019 · US
US-10172581-B2 · Jan 8, 2019 · US
US-2018251860-A1 · Sep 6, 2018 · US
Latest publications not already listed above.
US-10000815-B2 · Jun 19, 2018 · US
US-2016269319-A1 · Sep 15, 2016 · US
US-2016220208-A1 · Aug 4, 2016 · US
US-2015176081-A1 · Jun 25, 2015 · US
US-9055414-B2 · Jun 9, 2015 · US
US-9035036-B2 · May 19, 2015 · US
US-8996423-B2 · Mar 31, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Dana Farber Cancer Inst Inc | 12 |
| Massachusetts Gen Hospital | 8 |
| Microsoft Technology Licensing Llc | 5 |
| Gen Hospital Corp | 2 |
| Johnson Bruce E | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N33/575 | 9 |
| G01N2800/52 | 9 |
| G01N33/5752 | 9 |
| C12Q2600/158 | 7 |
| G01N2333/485 | 7 |